Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women, JAMA, vol.289, issue.24, pp.3243-53, 2003. ,
DOI : 10.1001/jama.289.24.3243
National Use of Postmenopausal Hormone Therapy, JAMA, vol.291, issue.1, pp.47-53, 2004. ,
DOI : 10.1001/jama.291.1.47
Differential effects of reproductive factors on the risk of pre-and post-menopausal breast cancer. Results from a large cohort of French women, Br J Cancer, vol.4, pp.723-730, 2002. ,
Nutrition and cancer: Background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC), Annals of Oncology, vol.3, issue.10, pp.783-91, 1992. ,
DOI : 10.1093/oxfordjournals.annonc.a058097
Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin, Journal of the National Cancer Institute, vol.92, issue.4, pp.328-360, 2000. ,
DOI : 10.1093/jnci/92.4.328
Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk, JAMA, vol.283, issue.4, pp.485-91, 2000. ,
DOI : 10.1001/jama.283.4.485
Estrogen-progestin replacement therapy and breast cancer risk: the Women's Health Study (United States), Cancer Causes and Control, vol.13, issue.9, pp.847-54, 2002. ,
DOI : 10.1023/A:1020617415381
Hormone Replacement Therapy Regimens and Breast Cancer Risk, Obstetrics & Gynecology, vol.100, issue.6, pp.1148-58, 2002. ,
DOI : 10.1097/00006250-200212000-00003
Relationship Between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast Cancer, JAMA, vol.289, issue.24, pp.3254-63, 2003. ,
DOI : 10.1001/jama.289.24.3254
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy, International Journal of Cancer, vol.4, issue.3, pp.339-383, 1999. ,
DOI : 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6
Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement, Cancer Causes and Control, vol.10, issue.4, pp.253-60, 1999. ,
DOI : 10.1023/A:1008909128110
Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden, Cancer, vol.336, issue.6, pp.1387-92, 2003. ,
DOI : 10.1002/cncr.11205
A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden), Cancer Causes and Control, vol.14, issue.7, pp.673-680, 2003. ,
DOI : 10.1023/A:1025635720208
Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe, International Journal of Cancer, vol.76, issue.5, pp.721-727, 2004. ,
DOI : 10.1002/ijc.20016
The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer, European Journal of Cancer and Clinical Oncology, vol.24, issue.1 ,
DOI : 10.1016/0277-5379(88)90173-3
Morphological evaluation of cell turnover in relation to the menstrual cycle in the ???resting??? human breast, British Journal of Cancer, vol.44, issue.2, pp.177-81, 1981. ,
DOI : 10.1038/bjc.1981.168
Proliferative and secretory activity in human breast during natural and artificial menstrual cycles, Am J Pathol, vol.130, pp.193-204, 1988. ,
The effect of age and menstrual cycle upon proliferative activity of the normal human breast, British Journal of Cancer, vol.58, issue.2, pp.163-70, 1988. ,
DOI : 10.1038/bjc.1988.185
The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice, Cancer, vol.39, issue.9, pp.1920-1927, 1984. ,
DOI : 10.1002/1097-0142(19841101)54:9<1920::AID-CNCR2820540924>3.0.CO;2-F
Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo**Supported by Besins-Iscovesco, Paris, France and Orient Europharma, Taipei, Taiwan.??????Presented in part at the 7th International Congress on the Menopause, Stockholm, Sweden, June 20 to 24, 1993., Fertility and Sterility, vol.63, issue.4, pp.785-91, 1995. ,
DOI : 10.1016/S0015-0282(16)57482-2
Estradiol and Progesterone Regulate the Proliferation of Human Breast Epithelial Cells, Fertility and Sterility, vol.69, issue.5, pp.963-972, 1998. ,
DOI : 10.1016/S0015-0282(98)00042-9
Postmenopausal Hormone Therapy and Change in Mammographic Density, JNCI Journal of the National Cancer Institute, vol.95, issue.1, pp.30-37, 2003. ,
DOI : 10.1093/jnci/95.1.30
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women, New England Journal of Medicine, vol.332, issue.24, pp.1589-93, 1995. ,
DOI : 10.1056/NEJM199506153322401
Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening, International Journal of Cancer, vol.3, issue.5, pp.758-61, 1997. ,
DOI : 10.1002/(SICI)1097-0215(19970904)72:5<758::AID-IJC9>3.0.CO;2-R
Hormone Replacement Therapy in Relation to Breast Cancer, JAMA, vol.287, issue.6, pp.734-775, 2002. ,
DOI : 10.1001/jama.287.6.734
Conjugated estrogens and breast cancer risk, Gynecol Endocrinol, vol.13, issue.6, pp.13-22, 1999. ,
Potential impact on breast cancer risk of circulating insulin???like growth factor I modifications induced by oral HRT in menopause, Gynecological Endocrinology, vol.52, issue.1, pp.67-74, 1995. ,
DOI : 10.1210/edrv-11-2-266
Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study, J Clin Endocrinol Metabol, vol.81, pp.2848-53, 1996. ,
Circulating concentrations of insulin-like growth factor I and risk of breast cancer, The Lancet, vol.351, issue.9113, pp.1393-1399, 1998. ,
DOI : 10.1016/S0140-6736(97)10384-1
Serum insulin-like growth factor-I and breast cancer, Int J Cancer, vol.88, pp.828-860, 2000. ,
Fasting glucose is a risk factor for breast cancer: a prospective study, Cancer Epidemiol Biomarkers Prev, vol.11, pp.1361-1369, 2002. ,
Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC), Public Health Nutrition, vol.288, issue.6b, pp.1147-62, 2002. ,
DOI : 10.1093/ije/26.suppl_1.S6
Problems Involved in Including Women with Simple Hysterectomy in Epidemiologic Studies Measuring the Effects of Hormone Replacement Therapy on Breast Cancer Risk, American Journal of Epidemiology, vol.147, issue.8, pp.718-721, 1998. ,
DOI : 10.1093/oxfordjournals.aje.a009515
Bias in Breast Cancer Analyses Due to Error in Age at Menopause, American Journal of Epidemiology, vol.151, issue.4, pp.404-408, 2000. ,
DOI : 10.1093/oxfordjournals.aje.a010220
Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review, Journal of Medical Screening, vol.8, issue.1, pp.29-34, 2001. ,
DOI : 10.1136/jms.8.1.29
Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhone programme, Journal of Medical Screening, vol.6, issue.2, pp.99-102, 1999. ,
DOI : 10.1136/jms.6.2.99